ClinicalTrials.gg
RecruitingNCT07541924LOOP-p1Updated Apr 21, 2026

The Impact of Image-Assisted Colonoscope on Patient Experience, Physician Workload, and Examination Quality

An interventional study of CT-Based Image-Assisted Colonoscope Insertion in Colorectal Cancer Screening, Colonic Polyps/Colonoscopy/Colorectal Neoplasms and Difficult Colonoscopy, sponsored by DONG WU. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-21.

Sponsored by DONG WU · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Colonoscopy is the cornerstone for colorectal cancer screening, diagnosis, and post-treatment surveillance. Procedural quality is influenced by patient anatomy, particularly variations in colonic configuration such as sigmoid redundancy, looping, and low-lying transverse colon. These features prolong insertion time, increase patient discomfort, and elevate physician workload.

Evidence suggests that prior CT imaging can provide objective and individualized information on colonic anatomy-such as redundancy, angulation, and tortuosity-potentially predicting procedural difficulty. However, existing studies are mainly retrospective or descriptive, lacking prospective randomized evidence on clinical utility.

This single-blind, randomized controlled trial evaluates whether image-assisted colonoscope insertion, based on pre-existing abdominal/pelvic CT scans, can improve cecal intubation time, enhance patient experience, reduce operator workload, and improve overall examination quality compared with standard colonoscopy.

Read the detailed description

Colonoscopy performance varies widely among patients, with anatomical factors being major contributors to insertion difficulty. Prior CT colonography studies demonstrate high interindividual variability in colon length, flexures, and tortuosity, and up to 73% of patients experience looping during colonoscopy. Fluoroscopy-guided maneuvers have been shown to resolve looping in >95% of cases, highlighting the potential value of anatomical prediction.

This study investigates the feasibility and effectiveness of using information extracted from a patient's previous abdominal/pelvic CT scan (≤5 years) to guide insertion strategy during colonoscopy. Image-assisted guidance may help endoscopists anticipate looping patterns, identify redundant segments, and plan insertion maneuvers more effectively.

A total of 140 participants will be randomized 1:1 into an image-assisted group or standard group. The primary endpoint is cecal intubation time. Secondary endpoints include patient-reported pain (VAS), willingness for future colonoscopy, operator workload (NASA-TLX), looping events, total procedure time, and polyp detection rate. Consistency between CT-based predictions and actual procedural findings will also be assessed.

This trial will provide foundational evidence for individualized, anatomy-informed colonoscopy strategies and support future large-scale studies or AI-assisted implementation.

02

Conditions studied

  • Colorectal Cancer Screening
  • Colonic Polyps/Colonoscopy/Colorectal Neoplasms
  • Difficult Colonoscopy
  • Colonoscopy-Related Discomfort

Browse trials for

Keywords

  • Colonoscopy
  • Cecal Intubation Time
  • Looping
  • Image-Assisted Colonoscopy
  • Personalized Colonoscopy
03

In context

Colonic Polyps

377 studies on the registry are indexed under Colonic Polyps; 57 are open to participants now.

This study's planned enrollment of 200 is below the median of 274 across 250 interventional studies indexed under Colonic Polyps.

Browse Colonic Polyps studies →

Lead sponsor

This is the only study on the registry with DONG WU as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-80 years, or expected natural survival >3 years
  • Undergoing colonoscopy at Peking Union Medical College Hospital
  • Presence of an abdominal/pelvic CT scan performed within ≤5 years and no - - - major abdominal surgery afterward
  • Patient or legal guardian able to understand the study and provide written consent

Exclusion criteria

Exclusion Criteria:

  • No available CT or CT quality insufficient for anatomical evaluation
  • Prior colonic surgery affecting anatomy (e.g., right hemicolectomy, transverse colectomy)
  • Severe cardiopulmonary dysfunction or coagulopathy
  • Pregnancy
  • Refusal to participate or inability to complete questionnaires
  • Patient or guardian unable to understand study requirements
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Image-Assisted Colonoscopy

    Participants undergo colonoscopy with pre-procedural review of their existing abdominal/pelvic CT scan (≤5 years). Endoscopists complete a standardized imaging assessment form including predicted redundancy, looping type, tortuosity, and segmental laxity. No additional imaging is performed.

    Other: CT-Based Image-Assisted Colonoscope Insertion

  • No intervention
    Standard Colonoscopy

    Participants undergo colonoscopy per routine clinical practice without CT-based anticipatory guidance.

Interventions

  • OtherCT-Based Image-Assisted Colonoscope Insertion

    This intervention uses pre-existing abdominal or pelvic CT imaging (within 5 years, without major abdominal surgery) to assess individual colonic morphology prior to colonoscopy. Key CT-derived features include colonic redundancy, looping patterns, fixation points, and segmental angulation. Based on these findings, the endoscopist receives a structured, standardized briefing before colonoscope insertion, including predicted difficult segments and recommended insertion strategies. No additional imaging, radiation, or invasive procedures are used. The intervention aims to improve insertion efficiency, reduce patient discomfort, and lower operator workload compared with standard colonoscopy without image guidance.

06

What researchers measure

Primary outcomes

  1. Cecal Incubation Time (minutes)

    Time from scope insertion to visualization of the cecum

    Time frame: Periprocedural (during colonoscopy procedure)

Secondary outcomes

  1. Pain Score (VAS 0-10)

    Patient-reported pain assessed using a Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (worst pain imaginable).

    Time frame: Immediately after colonoscopy (periprocedural)

  2. Physician Workload

    NASA-TLX Score (0-100)

    Time frame: Immediately after colonoscopy

  3. Willingness for Future Colonoscopy (5-point Likert scale)

    Patient willingness to undergo repeat colonoscopy assessed using a 5-point Likert scale.

    Time frame: Immediately after colonoscopy

  4. Polyp Detection Rate (PDR) (%)

    Proportion of colonoscopies in which at least one polyp is detected.

    Time frame: During colonoscopy procedure

  5. Number of Looping Attempts

    Total number of looping events requiring corrective maneuvers during colonoscope insertion.

    Time frame: During colonoscopy procedure

Other outcomes

  1. Agreement Between CT-Based Prediction and Procedural Findings

    Agreement between pre-procedural CT-based anatomical predictions and actual procedural findings, including predicted looping type, colonic redundancy, and insertion difficulty grade, assessed using Cohen's kappa statistics.

    Time frame: During colonoscopy procedure

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — The individual participant data (IPD) will not be shared. Only aggregated results will be published.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2025 to primary completion in Jan 2026, 1 month.

Of 132 non-industry interventional studies with no phase under Colonic Polyps, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 35. This study's 1 month is below that.

Counting every sponsor, half of 149 studies reached it within 17 months; a quarter within 9 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2025
First posted
Apr 21, 2026
StartActual
Dec 9, 2025
Primary completionActual
Jan 30, 2026
CompletionEst.
May 28, 2026
Last update
Apr 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07541924
Lead sponsor
DONG WU
Responsible party
DONG WU (Professor of Medicine, Peking Union Medical College Hospital) — Sponsor-investigator
First posted
Apr 21, 2026
Start date
Dec 9, 2025
Primary completion
Jan 30, 2026
Completion
May 28, 2026 (estimated)
Last update
Apr 21, 2026

Study contacts

Kun He, MD
Contact
hk6290418@163.com
15901623698

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion